International Journal of Clinical Oncology

Papers
(The H4-Index of International Journal of Clinical Oncology is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Clinical and biological impact of SNAT7 in lung adenocarcinoma: implications for prognosis and treatment130
Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolution101
Predictive role of circulatory levels of high-mobility group box 1 for radiation pneumonitis in patients with non-small cell lung cancer treated with definitive thoracic radiotherapy59
Online peer support for breast cancer survivors: protocol for a decentralized multicenter open-label pilot randomized controlled trial (HOPE-BC study)56
Critical evaluation of “Long-term clinical outcome of lung radiofrequency ablation in patients with musculoskeletal sarcoma”34
The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan32
Indocyanine green-guided sentinel lymph node mapping during laparoscopic surgery with vaginal cuff closure but no uterine manipulator for cervical cancer32
Macroscopic and multiple metastases in sentinel lymph node biopsy are respectively associated with poor prognosis in early oral cancer31
Onco-nephrology in clinical practice: pharmacokinetics, monitoring, and treatment strategies for patients with cancer and impaired renal function30
Nationwide genomic data analysis of central nervous system tumors in Japan based on C-CAT database28
Long-term survival outcome of locally advanced gastric cancer patients who achieved a pathological complete response to neoadjuvant chemotherapy28
Efficacy of bepotastine compared with hydroxyzine in preventing rituximab-induced infusion-related reactions in non-hodgkin lymphoma patients: a phase II, double-blind, multicenter, and randomized tri26
Validation of the 9th Edition of the UICC TNM classification and the prognostic impact of nodal spread in salivary gland cancer26
Impact of breast cancer surgical procedures on postoperative daily life: a multicenter patient-reported outcomes study25
Perioperative chemotherapy for clinical stage IIIB gallbladder cancer: a review of the National Cancer Database25
Rac1 activation in oral squamous cell carcinoma as a predictive factor associated with lymph node metastasis23
Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan23
Music therapy preferences among breast cancer patients undergoing perioperative chemotherapy: from qualitative insight to quantitative evidence23
The efficacy and safety of lenvatinib plus pembrolizumab in vulnerable patients with metastatic or recurrent endometrial cancer: a single institution experience22
Longitudinal assessment of health-related quality of life, sleep quality, and gustation in patients with advanced urothelial carcinoma receiving late-line enfortumab vedotin monotherapy22
Efficacy and safety of adjuvant nivolumab after radical surgery for high-risk urothelial carcinoma: a preliminary report of real-world data from a single institution21
Socioeconomic disparities in colorectal cancer oncologic emergencies: a nationwide multilevel analysis in Japan21
Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity21
0.19465613365173